Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome

BACKGROUND: Metabolic syndrome (MetS) is associated with an increased risk of the development of atherosclerotic cardiovascular disease (CVD). Interleukin-18 (IL-18), which is a pleiotropic proinflammatory cytokine with important regulatory functions in the innate immune response system, plays a cru...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaoka-Tojo, Minako, Tojo, Taiki, Wakaume, Kazuki, Kameda, Ryo, Nemoto, Shinji, Takahira, Naonobu, Masuda, Takashi, Izumi, Tohru
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038890/
https://www.ncbi.nlm.nih.gov/pubmed/21251304
http://dx.doi.org/10.1186/1743-7075-8-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038890/
https://www.ncbi.nlm.nih.gov/pubmed/21251304
http://dx.doi.org/10.1186/1743-7075-8-3

Ejemplares similares